Potent and sequence-specific removal through genome targeting with CRISPR-Cas systems. Potent and sequence-specific removal through genome targeting with.

Slides:



Advertisements
Similar presentations
A b Fig. S1 Expression constructs for Cas9 without DsRed gene, and Cas9 mRNA level in pZD_Cas9 transformed calli. a pZH_Cas9 without the DsRed expression.
Advertisements

Figure 1. AsCpf1 and LbCpf1-mediated gene editing in human cells
Molecular recordings by directed CRISPR spacer acquisition
Molecular Cloning.
Volume 161, Issue 5, Pages (May 2015)
Expanding the Biologist’s Toolkit with CRISPR-Cas9
PCR genotype analysis to determine RNP-mediated knockout efficiency in C. lusitaniae. PCR genotype analysis to determine RNP-mediated knockout efficiency.
CRISPR-Cas Systems: Prokaryotes Upgrade to Adaptive Immunity
Volume 56, Issue 4, Pages (November 2014)
Dan Ding, Kaiyuan Chen, Yuedan Chen, Hong Li, Kabin Xie 
Volume 22, Issue 13, Pages (March 2018)
In vivo optimization of the tagging approach using the Act5C model locus and flow cytometry-based quantification of the Act5C-GFP tagging success. In vivo.
Rewiring Cas9 to Target New PAM Sequences
Figure 2 Use of CRISPR/Cas9 for genome editing
Chaoyou Xue, Natalie R. Whitis, Dipali G. Sashital  Molecular Cell 
Schematic representation of the MAT loci of S. pombe, P. jirovecii, P
Strategy for CRISPR/Cas9-mediated genome editing in ΔEx50 mice
DNase H Activity of Neisseria meningitidis Cas9
by Luciano A. Marraffini, and Erik J. Sontheimer
Harnessing CRISPR–Cas systems for bacterial genome editing
Volume 58, Issue 1, Pages (April 2015)
CRISPR-Cas Systems: Prokaryotes Upgrade to Adaptive Immunity
Addison V. Wright, James K. Nuñez, Jennifer A. Doudna  Cell 
Genomic rearrangements of E
Volume 62, Issue 1, Pages (April 2016)
Mouse Genome Engineering via CRISPR-Cas9 for Study of Immune Function
Volume 65, Issue 1, Pages (January 2017)
Figure 1 Adaptive immune system of bacteria and archaea
Molecular Therapy - Nucleic Acids
CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles
Therapeutic editing of hepatocyte genome in vivo
USH2A Gene Editing Using the CRISPR System
Joseph Bondy-Denomy, Alan R. Davidson  Trends in Microbiology 
Objective: Convert a hulled (covered) barley into a hull-less (Naked
Guide RNA Functional Modules Direct Cas9 Activity and Orthogonality
Volume 22, Issue 3, Pages e3 (September 2017)
Volume 48, Issue 5, Pages (December 2012)
Venn diagram of blaKPC-containing plasmids detected in the environment and patients. Venn diagram of blaKPC-containing plasmids detected in the environment.
Volume 164, Issue 1, Pages (January 2016)
Andrew R. Bassett, Charlotte Tibbit, Chris P. Ponting, Ji-Long Liu 
Volume 154, Issue 6, Pages (September 2013)
Volume 153, Issue 4, Pages (May 2013)
Programmable RNA Cleavage and Recognition by a Natural CRISPR-Cas9 System from Neisseria meningitidis  Beth A. Rousseau, Zhonggang Hou, Max J. Gramelspacher,
Volume 69, Issue 5, Pages e7 (March 2018)
Gang Wang, Na Zhao, Ben Berkhout, Atze T Das  Molecular Therapy 
Volume 69, Issue 1, Pages e3 (January 2018)
A CRISPR Approach to Gene Targeting
William T. Hendriks, Curtis R. Warren, Chad A. Cowan  Cell Stem Cell 
Volume 153, Issue 4, Pages (May 2013)
Volume 15, Issue 3, Pages (April 2016)
Molecular Therapy - Nucleic Acids
Hybridization Kinetics Explains CRISPR-Cas Off-Targeting Rules
Tagging of the endogenous Py03652 gene with the gfp gene in Plasmodium yoelii. Tagging of the endogenous Py03652 gene with the gfp gene in Plasmodium yoelii.
Generation of heterozygous mutations with the CRISPR-Cas9 system.
The SyngenicDNA approach applied to Staphylococcus aureus JE2.
Fig. 4 Gene disruption via chip.
Fig. 6. F1 trβ mutants accomplish natural metamorphosis.
Editing and reconstitution of CPAR2_
Adaptation in CRISPR-Cas Systems
Volume 16, Issue 11, Pages (September 2016)
Volume 26, Issue 11, Pages (November 2018)
Recombination of a Cas9-created DNA fragment with and without end repair. Recombination of a Cas9-created DNA fragment with and without end repair. (A)
Fig. 1 Exon 44–deleted DMD patient iPSC-derived cardiomyocytes express dystrophin after CRISPR-Cas9–mediated genome editing. Exon 44–deleted DMD patient.
by Pan Tao, Xiaorong Wu, and Venigalla Rao
CRISPR Immunological Memory Requires a Host Factor for Specificity
Volume 25, Issue 4, Pages e3 (October 2018)
Genome-Edited Triple-Recessive Mutation Alters Seed Dormancy in Wheat
ChIP-chip analysis of wild-type (WT) and RpoZ-defective mutant RNAP
Knock-in of the rpl42-P56Q mutation using the split-ura4 system.
Fig. 3 Genome editing of the MSTN gene.
Presentation transcript:

Potent and sequence-specific removal through genome targeting with CRISPR-Cas systems. Potent and sequence-specific removal through genome targeting with CRISPR-Cas systems. (A) Design of a CRISPR RNA targeting the ftsA gene in E. coli K-12. The 32-nt spacer sequence is in blue, and the repeat sequence is in gray. The last two nucleotides of the spacer (in black) are fixed to introduce restriction sites used for cloning additional repeat-spacer pairs. Flanking the protospacer (highlighted in blue) is the protospacer-adjacent motif (PAM) (highlighted in green) required for DNA targeting. Point mutations within the established seed region of the spacer (9) and the protospacer tested in panel B are shown. (B) Transformation efficiencies of α-ftsA plasmids containing different mutations in the seed region of the spacer. Single, double, and triple mutations of the spacer sequence are shown in yellow, orange, and red, respectively. The transformations were carried out in BW25113-T7 (wild type [WT]) or BW25113-T7m257′ (m2,5,7′), each harboring two plasmids: pCas3 (+ cas3) and either pCasA-E (+ casABCDE) or pCasA-E′ (− casABCDE). Figure S1 in the supplemental material illustrates the general transformation procedure. Transformation efficiency was calculated as the number of transformants for each tested plasmid divided by the number of transformants for the original pCRISPR plasmid for the same culture. Values represent the geometric means and SEM of data from three independent experiments. Ahmed A. Gomaa et al. mBio 2014; doi:10.1128/mBio.00928-13